Androgen Receptor Emerges as a Marker of Differentiation in Endometrial Cancer
Early-Onset Endometrial Cancer: Bridging the Gap Between Age and Outcome
Redefining Risk in Endometrial Cancer: Recurrence Prediction with Machine Learning
Stratifying Advanced Endometrial Cancer: Real-World Outcomes by Molecular Subtype
Advancing Patient-Centered Care in HER2-Positive Metastatic Breast Cancer
Megan Kruse, MD
Optimizing Quality of Life in HER2+ Metastatic Breast Cancer
Refining First-Line Therapy in Advanced Endometrial Care: LEAP-001 Trial Results
Oral Contraceptives and Endometrial Cancer: Examining a Potential Dose-Response Protective Effect
Balancing Efficacy and Tolerability in Metastatic Breast Cancer Treatment
Paolo Tarantino, MD
Navigating Metastatic Breast Cancer Care: Key Factors in Decision-Making
HER2 Testing: The Evolving Role of Immunohistochemistry (IHC)
Fernando López-Ríos, MD, PhD
Christian Rolfo, MD, PhD
Charlie Gourley, MD, PhD
Reducing Patient Time Burden in HER2+ Breast Cancer with Subcutaneous Trastuzumab/Pertuzumab
Sacituzumab Govitecan for mTNBC: A Review of Real-World Efficacy and Safety Data
Charles Turck, PharmD, BCPS, BCCCP
Early-Stage Breast Cancer Care: Treatment Selection Strategies and Challenges
Adrienne Waks, MD
Detecting Recurrent Breast Cancer: The Role of Liquid Biopsies and Molecular Markers
Ben Park, MD, PhD
Understanding Bone Metastases in Breast Cancer: Impacts and Treatment Approaches
Rachelle W. Johnson, PhD
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.